German company announced the development of rapid detection reagent 2.5 hours results

category:Hot
 German company announced the development of rapid detection reagent 2.5 hours results


Bosch (Germany) and Randox (UK) have jointly developed one of the worlds first full-automatic molecular diagnostic reagents for the new coronavirus, the German business daily and Frankfurt report reported Tuesday. The reagent took six weeks to develop.

(function(){(window.slotbydup=window.slotbydup||[]).push({id:u5811557,container:ssp_5811557,async:true});})(); The report quoted Bosch as saying that the detection process of the reagent is very easy to operate and does not need special trained personnel: collect the nose swab or throat swab of the test object, put the sample into the kit already equipped with the detection reagent, then insert it into the analytical instrument, the test can be completed, and the results can be known on site within two and a half hours. In addition, each analyzer can be tested up to 10 times in 24 hours. According to Bosch, the method has reached more than 95% accuracy in different laboratories and meets the quality standards of the World Health Organization. In addition to the detection of new coronavirus, the rapid detection agent can also use the same sample to detect nine other respiratory diseases, including influenza A and B. The reagent will be used in Germany from April. According to the business daily, Bosch is similar to the rapid detection reagent developed by Cepheid, an American company. On March 22, the U.S. Food and Drug Administration (FDA) approved the test reagent, which can get the test results in about 45 minutes. The novel coronavirus pneumonia is diagnosed by the global single day diagnosis. Nearly 50 thousand cases have been confirmed in the world. The number of deaths in Europe has exceeded 250 thousand for 7 consecutive days. The death rate exceeds six hundred. The high mortality rate in Italy has not slowed down. Panama has added 116 cases of new crown pneumonia confirmed cases to 674 cases. The source: surging news editor: Zhao Li Xian _NAG3173

The report quoted Bosch as saying that the detection process of the reagent is very easy to operate and does not need special trained personnel: collect the nose swab or throat swab of the test object, put the sample into the kit already equipped with the detection reagent, then insert it into the analytical instrument, the test can be completed, and the results can be known on site within two and a half hours. In addition, each analyzer can be tested up to 10 times in 24 hours.

According to Bosch, the method has reached more than 95% accuracy in different laboratories and meets the quality standards of the World Health Organization. In addition to the detection of new coronavirus, the rapid detection agent can also use the same sample to detect nine other respiratory diseases, including influenza A and B. The reagent will be used in Germany from April.

According to the business daily, Bosch is similar to the rapid detection reagent developed by Cepheid, an American company. On March 22, the U.S. Food and Drug Administration (FDA) approved the test reagent, which can get the test results in about 45 minutes.